1992
DOI: 10.1101/gad.6.4.545
|View full text |Cite
|
Sign up to set email alerts
|

Serum-, TPA-, and Ras-induced expression from Ap-1/Ets-driven promoters requires Raf-1 kinase.

Abstract: Raf-1 serine-threonine protein kinase has the hallmarks of a critical switch that connects growth factor receptor activation at the cell membrane with transcriptional events in the nucleus. We show by use of Raf-1 dominant-negative mutants that Raf-1 is required for serum-, TPA-, and Ras-induced expression from the oncogene-responsive element in the polyomavirus enhancer. The minimal region of Raf-1 that displays this dominant-negative phenotype (Raf-C4] contains a cysteine finger motif. Raf-C4 appears to func… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

16
362
0
1

Year Published

1996
1996
2009
2009

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 446 publications
(379 citation statements)
references
References 49 publications
(56 reference statements)
16
362
0
1
Order By: Relevance
“…To further con®rm the involvement of these pathways, we carried out Elk-1 transactivation studies with dominant negative constructs of Raf-1 and the p85 subunit of PI3 kinase (Bruder et al, 1992;Brennan et al, 1997). These constructs did not only abrogate the DHT e ect but they also reduced the basal activity which possibly arose as a result of residual hormone in the culture medium (Figure 5a).…”
Section: Sensitivity To Kinase Inhibitorsmentioning
confidence: 99%
See 1 more Smart Citation
“…To further con®rm the involvement of these pathways, we carried out Elk-1 transactivation studies with dominant negative constructs of Raf-1 and the p85 subunit of PI3 kinase (Bruder et al, 1992;Brennan et al, 1997). These constructs did not only abrogate the DHT e ect but they also reduced the basal activity which possibly arose as a result of residual hormone in the culture medium (Figure 5a).…”
Section: Sensitivity To Kinase Inhibitorsmentioning
confidence: 99%
“…Kinase inhibitors PD98059, GF109203X, and Wortmannin were all purchased from Calbiochem (Bad Soden/Taunus, Germany). The indicator gene consisting of GAL 4 DNA binding sites controlling the expression of a luciferase gene pG5.E4D38lux3, the expression vector containing the GAL 4 DNA binding domain (DBD) alone or linked to the transcription factor Elk-1, the empty expression vector containing the RSV promoter RSV-H20 and the RSV promoter driving the expression of a dominant negative Raf-1 sequence RSV-cRafC4 have all been described (O ringa et al, 1990;Bruder et al, 1992;Gille et al, 1995b;Kamano et al, 1995).…”
Section: Materials and Plasmid Constructsmentioning
confidence: 99%
“…The ERK1 and ERK2 constructs contain the coding region of these MAPKs in which the conserved lysine involved in phosphate transfer (codon 71 and 52 for ERK1 and ERK2 respectively) has been changed to arginine thus impairing the catalytic e ciency (Frost et al, 1994). The Raf C4 expression plasmid encodes the c-Raf-1 protein lacking the kinase domain (Bruder et al, 1992). The MEK DN3S218E-S222D construct encodes the MEK1 sequence in which residues 32 ± 51 at the aminoterminus have been deleted and in which the serines at position 218 and 222 have been replaced by glutamate and aspartate respectively (Mansour et al, 1994).…”
Section: Vectors and Antibodiesmentioning
confidence: 99%
“…Our results indicate that the activation of c-jun is a consequence of JNK-1 and c-Raf-1 activation. c-Raf-1 may exert nuclear events directly after translocating to the nucleus where it enhances the expression of several genes, including c-jun, through Ets-1 and AP-1-binding sites [55][56][57]. Also, c-Raf-1 phosphorylates c-jun [58].…”
mentioning
confidence: 99%